Bill Gates Says Misinformation Related To Fauci, Himself Doesn't 'Make Sense,' Talks COVID-19 After Omicron

Microsoft Corporation MSFT co-founder Bill Gates answered questions related to COVID-19 on Twitter Tuesday.

What Happened: The questions to Gates were routed through Devi Sridhar, director of Global Health Governance and a professor at the University of Edinburgh Medical School.

Gates said while the current vaccines prevent severe disease and death very well, they still allow breakthrough infections and their efficacy duration appears to be limited. 

“We need vaccines that prevent re-infection and have many years of duration.”

The former Microsoft executive addressed online misinformation — particularly that related to him and the Chief Medical Advisor to the President of United States Anthony Fauci — in the Twitter exchange with Sridhar.


On the progress of the COVID-19 pandemic through 2022, Gates struck a somewhat optimistic note.

See Also: How To Buy Microsoft (MSFT) Shares

Why It Matters: Gates is the co-chair of The Bill & Melinda Gates Foundation, which has committed more than $1.9 billion to support the global response to COVID-19.

In the early days of the COVID-19 pandemic, the Gates Foundation backed vaccine makers such as Inovio Pharmaceuticals Inc INO and others.

Several conspiracy theories have emerged around Gates last year as the pandemic gripped the world, which he said were “almost hard to deny” because ‘it’s so stupid,” reported Business Insider.

Price Action: On Tuesday, Microsoft shares closed 0.2% higher at $314.98 in the regular session.

Read Next: Bill Gates To Oust Ex-Wife Melinda From Couples' Foundation If Divorced Pair Finds They Can't Get Along

Photo: Courtesy of Kuhlmann via Wikimedia

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapAnthony FauciBill GatesCoronavirusCovid-19OmicronPandemic
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!